News
CARGO offloads staff after abandoning lead CAR-T
Less than 18 months after its IPO, CAR-T developer CARGO has abandoned its development efforts and slashed around 90% of its staff.
News
Roche taps Oxford BioTherapeutics for cancer drug discovery
Oxford BioTherapeutics has lined up another big pharma partner for its drug discovery platform, signing a $1bn deal with oncology giant Roche.
News
Sofinnova closes new fund and backs a trio of new biotechs
Sofinnova Partners has raised €165m for its new biotech fund and backed three startups working on Alzheimer's, fibrotic diseases, and cell therapies.
News
AstraZeneca buys cell therapy biotech for up to $1bn
AstraZeneca plans to acquire Belgian in vivo cell therapy biotech EsoBiotec and has signed a pair of licensing deals with drug delivery firm Alteogen.
News
Taiho snaps up ADC partner Araris for up to $1.14bn
Taiho has reached a deal to buy Swiss biotech Araris, around 18 months after they started collaborating on antibody-drug conjugates for cancer.
News
Views & Analysis
Deep Dive
Editor's Picks
Editor's Picks
